On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare's most fundamental tools.

Medtronic holds a dominant share in the market for pulse oximeters, Aboelata said. “Ultimately, we want the FDA to hold themselves and manufacturers accountable for ensuring the devices work for ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

In response to this rising demand, the global market for glucose monitoring devices is projected to experience significant growth, with an anticipated compound annual growth rate (CAGR) of 10.6% over ...

(GPx), a fast-growing MedTech startup revolutionizing chronic disease monitoring and management ... and sales in healthcare and medical devices. Its co-founders Sean Matsuoka and Javier Echenique have ...